Details for New Drug Application (NDA): 202284
✉ Email this page to a colleague
The generic ingredient in FELBAMATE is felbamate. There are twelve drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the felbamate profile page.
Summary for 202284
Tradename: | FELBAMATE |
Applicant: | Ani Pharms |
Ingredient: | felbamate |
Patents: | 0 |
Pharmacology for NDA: 202284
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 202284
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FELBAMATE | felbamate | TABLET;ORAL | 202284 | ANDA | ANI Pharmaceuticals, Inc. | 62559-730 | 62559-730-01 | 100 TABLET in 1 BOTTLE (62559-730-01) |
FELBAMATE | felbamate | TABLET;ORAL | 202284 | ANDA | ANI Pharmaceuticals, Inc. | 62559-731 | 62559-731-01 | 100 TABLET in 1 BOTTLE (62559-731-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 400MG | ||||
Approval Date: | Nov 4, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Nov 4, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription